EXACT Sciences Corp. (DELISTED) (EXAS:DL)
104.91
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
EXACT Sciences Enterprise Value : 21.60B for April 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 02, 2026 | 21.60B |
| April 01, 2026 | 21.60B |
| March 31, 2026 | 21.60B |
| March 30, 2026 | 21.60B |
| March 27, 2026 | 21.60B |
| March 26, 2026 | 21.60B |
| March 25, 2026 | 21.60B |
| March 24, 2026 | 21.60B |
| March 23, 2026 | 21.60B |
| March 20, 2026 | 21.60B |
| March 19, 2026 | 21.41B |
| March 18, 2026 | 21.37B |
| March 17, 2026 | 21.41B |
| March 16, 2026 | 21.39B |
| March 13, 2026 | 21.34B |
| March 12, 2026 | 21.28B |
| March 11, 2026 | 21.31B |
| March 10, 2026 | 21.30B |
| March 09, 2026 | 21.37B |
| March 06, 2026 | 21.33B |
| March 05, 2026 | 21.29B |
| March 04, 2026 | 21.33B |
| March 03, 2026 | 21.30B |
| March 02, 2026 | 21.30B |
| February 27, 2026 | 21.30B |
| Date | Value |
|---|---|
| February 26, 2026 | 21.28B |
| February 25, 2026 | 21.28B |
| February 24, 2026 | 21.32B |
| February 23, 2026 | 21.31B |
| February 20, 2026 | 21.31B |
| February 19, 2026 | 21.29B |
| February 18, 2026 | 21.30B |
| February 17, 2026 | 21.29B |
| February 13, 2026 | 21.28B |
| February 12, 2026 | 21.28B |
| February 11, 2026 | 21.08B |
| February 10, 2026 | 21.06B |
| February 09, 2026 | 21.06B |
| February 06, 2026 | 21.03B |
| February 05, 2026 | 20.93B |
| February 04, 2026 | 20.86B |
| February 03, 2026 | 20.90B |
| February 02, 2026 | 20.90B |
| January 30, 2026 | 20.87B |
| January 29, 2026 | 21.09B |
| January 28, 2026 | 21.08B |
| January 27, 2026 | 21.10B |
| January 26, 2026 | 21.13B |
| January 23, 2026 | 21.08B |
| January 22, 2026 | 21.10B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 29.09B |
| Illumina, Inc. | 25.71B |
| Mettler-Toledo International, Inc. | 25.67B |
| Natera, Inc. | 30.96B |
| Abbott Laboratories | 186.33B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -85.96M |
| Revenue (Quarterly) | 878.38M |
| Total Expenses (Quarterly) | 964.34M |
| EPS Diluted (Quarterly) | -0.453 |
| Gross Profit Margin (Quarterly) | 70.11% |
| Profit Margin (Quarterly) | -9.79% |
| Earnings Yield | -1.05% |
| Normalized Earnings Yield | -0.874 |